 |
Kfx Medical’s SutureCross® System and PASTAFx™ System provides orthopaedic surgeons with versatility, strength and security for their patient needs.
KFx Medical is based in Carlsbad, California.
KFx Medical Corporation Announced Today It Has Received FDA 510k Clearance for Product(s) Used in a Wide Variety of Arthroscopic Tenodesis Knee Procedures Such as: ACL, PCL, and Patellofemoral Ligament (MPFL) Reconstruction
Carlsbad, CA, May 25, 2010 — KFx Medical Corporation announced today it has received FDA 510k clearance for product(s) used in a wide variety of arthroscopic tenodesis knee procedures such as: anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), and Medial Patellofemoral Ligament (MPFL) reconstruction
KFx Medical received 510k clearance from the Food and Drug Administration for its AppianFx™ product line for soft tissue repair and reconstruction in the knee. “The AppianFx for knee ligament/tissue fixation continues our focus on providing products, with broad intellectual protection, that enable surgeons to more quickly and easily perform complex procedures. This clearance to market our AppianFx family of implants significantly expands the number of surgical procedures for which we provide products to now include all extremities,” indicated Tate Scott, president and CEO of KFx Medical.
The AppianFx line of implants from KFx reattach tissue to bone in shoulder, knee, foot and ankle procedures which combined exceed well over 1 million annual surgical procedures. Product offerings include those that directly place and secure tissue into bone both with and without the use of sutures.
About KFx Medical Corporation
Headquartered in Carlsbad, Calif., KFx Medical Corporation was founded in 2003 to develop clinically relevant solutions to rotator cuff repair. Over four million people seek medical advice for shoulder pain every year; torn rotator cuffs alone account for more than 500,000 surgeries annually, requiring many months of rehabilitation. Traditional minimally invasive techniques, although promising (patients typically experience less pain and regain full range of motion more quickly) require surgeons to have advanced arthroscopy skills. In contrast, KFx provides simple systems for surgeons while ensuring a more anatomical repair for the patient, yielding better clinical outcomes. Investors include: Alloy Ventures, Arboretum Ventures, Charter Life Sciences, Montreux Equity Partners, and MB Venture Partners.# # #
Contact: |
 |
Tate Scott
President & CEO KFx Medical Corporation 5845 Avenida Encinas, Ste 128 Carlsbad, CA 92008 760.444.8820 Tate.Scott@kfxmed.com |